Aligos Therapeutics (ALGS) Other Non Operating Income (2019 - 2021)
Aligos Therapeutics' (ALGS) quarterly Other Non Operating Income came in at -$744000.0 in Q4 2021, down 490.48% YoY from $190536.6 in Q4 2020, and down 37100.0% on a QoQ basis from -$2000.0 in Q3 2021.
Aligos Therapeutics (ALGS) Other Non Operating Income (2019 - 2021) Analysis & Trends
Aligos Therapeutics (ALGS) has 3 years of Other Non Operating Income data on file, last reported at -$744000.0 in Q4 2021.
- Quarterly Other Non Operating Income fell 490.48% year-over-year to -$744000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$742000.0 (down 426.24% YoY) and the FY2025 annual result came in at $5000.0, down 95.15% from the prior year.
- Other Non Operating Income retreated to -$744000.0 in Q4 2021, from -$2000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $138000.0 in Q2 2020 to a low of -$744000.0 in Q4 2021.
- A 3-year average of -$81200.0 and a median of $2000.0 in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 101.2% in 2021, down 490.48% in 2021.
- Tracing ALGS's Other Non Operating Income over 3 years: stood at $33000.0 in 2019, then tumbled by 481.82% to -$126000.0 in 2020, then tumbled by 490.48% to -$744000.0 in 2021.
- The last three Other Non Operating Income figures came in at -$744000.0 (Q4 2021), -$2000.0 (Q3 2021), and $2000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aligos Therapeutics | 68.90 Mn | 38.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -744,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | -126,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 138,000.00 |
| Mar 31, 2020 | -166,000.00 |
| Dec 31, 2019 | 33,000.00 |
| Sep 30, 2019 | 38,000.00 |